Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PFN vs PCN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PCN Wins Head-to-Head Institutional Verdict (1–0 across 6 Pillars · 3–1 Matrix Metrics)

PCN Overall Winner 6-Pillar Tally: PFN 0 – 1 PCN (5 Tie) Matrix Metrics: PFN 1 – 3 PCN

As of Nov 16, 2026, PIMCO Corporate & Income Strategy Fund (PCN) is the stronger overall head-to-head candidate over PIMCO Income Strategy Fund II (PFN) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). PFN carries a Unified Composite Score of 40.0/100 (SELL) at $6.08 (N/M Forward P/E, N/A operating margin), whereas PCN carries 40.2/100 (SELL) at $10.49 (N/M Forward P/E, N/A operating margin).

  • Defensive Composite Rating Caution: Although PCN compares more favorably head-to-head, both PFN (40.0/100 SELL) and PCN (40.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: PFN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.1); meanwhile PCN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PFN vs PCN
PFN NYSE
PIMCO Income Strategy Fund II
Institutional Equity
$6.08
-0.65% 1D
Market Cap $715.5M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.45β · 19% Vol
Unified Composite Score
40.0 / 100 SELL
Tech 47.0 Fund 50.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 40
RSI-14: 40.1 · SMA20: $6.23 · SMA50: $6.31
PCN NYSE Head-to-Head Winner
PIMCO Corporate & Income Strategy Fund
Institutional Equity
$10.49
-1.32% 1D
Market Cap $894.5M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.45β · 19% Vol
Unified Composite Score
40.2 / 100 SELL
Tech 47.0 Fund 51.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 38
RSI-14: 38.1 · SMA20: $10.86 · SMA50: $10.90

6-Pillar Scorecard Institutional Category Breakdown (PFN 0 – 1 PCN)

Columns: Metric · PFN · PCN
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale PCN
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap $715.5M $894.5M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PFN (1) vs PCN (3)
Institutional Metric PFN PCN Criterion Row Edge
Market Capitalization
Scale
$715.5M $894.5M Larger Scale PCN
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
4% ($6–$8) 2% ($10–$13) Stronger Trend PFN
Beta / 30D Volatility
Risk Regime
0.45β · 19% Vol 0.45β · 19% Vol Lower Realized Risk PCN
Unified Institutional Score
Composite Signal
40.0 / 100 (SELL) 40.2 / 100 (SELL) Higher Composite PCN
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PCN +0.72 pp
PFN: -2.41% · PCN: -1.69%
3M Horizon PCN +3.37 pp
PFN: -13.64% · PCN: -10.27%
6M Horizon PCN +0.87 pp
PFN: -10.59% · PCN: -9.72%
1Y Horizon PCN +1.63 pp
PFN: -19.36% · PCN: -17.73%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PFN vs PCN. Trailing 12-month operating profitability (PFN N/A vs PCN N/A) and valuation multiples (PFN N/M vs PCN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

PFN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
PCN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PFN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PFN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PCN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PCN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PFN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $715.5M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
PCN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $894.5M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PFN vs PCN Key Questions & Quantitative Answers

As of Nov 16, 2026, PIMCO Corporate & Income Strategy Fund (PCN) is the stronger overall head-to-head candidate over PIMCO Income Strategy Fund II (PFN) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). PFN carries a Unified Composite Score of 40.0/100 (SELL) at $6.08 (N/M Forward P/E, N/A operating margin), whereas PCN carries 40.2/100 (SELL) at $10.49 (N/M Forward P/E, N/A operating margin). Defensive Composite Rating Caution: Although PCN compares more favorably head-to-head, both PFN (40.0/100 SELL) and PCN (40.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: PFN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.1); meanwhile PCN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PCN leads the Growth & Scale pillar: PFN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with PCN at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, PFN generates N/A in USD-normalized revenue versus N/A for PCN. In operating R&D and SG&A reinvestment, PFN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PCN.

PFN and PCN trade at balanced relative valuation multiples. PFN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PCN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PFN (N/A ROE) versus PCN (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, PFN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 19% Vol realized risk). By comparison, PCN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 19% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.